W3C home > Mailing lists > Public > public-lod@w3.org > June 2009

Re: LOD Data Sets, Licensing, and AWS

From: Hilmar Lapp <hlapp@gmx.net>
Date: Tue, 23 Jun 2009 21:40:39 -0400
Cc: Ian Davis <lists@iandavis.com>, public-lod@w3.org
Message-Id: <7B128437-9DA9-4D2F-B030-72E1AA9E6353@gmx.net>
To: Peter Ansell <ansell.peter@gmail.com>

On Jun 23, 2009, at 7:04 PM, Peter Ansell wrote:

> Interestingly, there is a large economy involved with patenting gene  
> sequences. Aren't they facts also? Why is patenting different to  
> copyright in this respect?


It isn't. I don't know of any gene sequence patent that was just that  
and withstood being challenged in court.

The gene sequence patents that I'm aware of and are active aren't for  
the sequence, but for an application of the sequence, such as as a  
diagnostic of a certain disease, or a drug target for a certain  
indication, or a biological therapeutic. Those kinds of discoveries  
aren't typically facts of nature, and hence eligible for intellectual  
property.

	-hilmar
-- 
===========================================================
: Hilmar Lapp  -:-  Durham, NC  -:-  hlapp at gmx dot net :
===========================================================
Received on Wednesday, 24 June 2009 08:22:02 UTC

This archive was generated by hypermail 2.3.1 : Sunday, 31 March 2013 14:24:21 UTC